GlassScriptPhysician profile
Peter V Nguyen
NPI 1790709285
$5,346.78
in general payments reported to CMS, 2019-2025
33 companies · $542 in 2025
The $542 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $703 · 2020: $287 · 2021: $700 · 2022: $1,490 · 2023: $901 · 2024: $723 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,122 · Education: $44.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,121.93 |
| Education | $44.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $855.64 | 2021-2025 | Tavneos, Krystexxa |
| Horizon Therapeutics Plc | $705.72 | 2019-2023 | Krystexxa |
| Vifor Pharma, INC. | $600.61 | 2020-2024 | Veltassa |
| Bayer Healthcare Pharmaceuticals INC. | $543.32 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $327.51 | 2019-2025 | Jynarque, Voyxact |
| Astrazeneca Pharmaceuticals LP | $312.78 | 2019-2023 | Farxiga |
| Philips North America LLC | $287.99 | 2019-2024 | (Br5) Peripheral Ivus |
| Cook Medical LLC | $206.86 | 2019-2022 | |
| Boston Scientific Corporation | $185.99 | 2021-2024 | Embold Fibered, Varithena Administration Pack |
| Cardiovascular Systems INC. | $163.20 | 2019-2021 | |
| Aurinia Pharma U.S., INC. | $130.35 | 2022-2025 | Lupkynis |
| Teleflex LLC | $112.97 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $101.56 | 2019 | |
| Travere Therapeutics, INC. | $99.53 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $68.86 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $64.09 | 2019-2023 | Ultomiris |
| Bard Peripheral Vascular, INC. | $60.79 | 2021 | |
| Penumbra, INC. | $55.63 | 2022 | |
| Medtronic, INC. | $53.78 | 2024 | Ellipsys Vascular Access System |
| Akebia Therapeutics INC | $49.36 | 2024 | Vafseo |
| Abbott Laboratories | $45.82 | 2024 | Amplatzer Amulet |
| Fresenius USA Marketing, INC. | $40.31 | 2021 | |
| Glaxosmithkline, LLC. | $39.96 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $33.31 | 2020 | |
| Novo Nordisk INC | $32.61 | 2021-2022 | |
| Tactile Systems Technology INC | $26.74 | 2024 | Flexitouch Plus, Entre Plus |
| Mallinckrodt Hospital Products INC. | $25.33 | 2025 | Terlivaz |
| Paratek Pharmaceuticals, INC. | $24.37 | 2024 | Nuzyra |
| Alnylam Pharmaceuticals INC. | $22.27 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $20.84 | 2023 | |
| W. L. Gore & Associates, INC. | $19.24 | 2021 | |
| Veloxis Pharmaceuticals, INC. | $18.24 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.